Business Context and Reporting Period
Company: DarioHealth Corp. (DRIO)
Filing Type: Form 8-K (Current Report)
Date of Report: August 25, 2025
Reporting Period: Event-specific report regarding a corporate action effective August 28, 2025.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on a capital structure adjustment.
Material Changes
The Company announced a 20-for-1 reverse stock split of its outstanding common stock. Key details include:
- Effective Date: August 28, 2025, at 12:01 a.m. Eastern Standard Time.
- Share Count Adjustment: Outstanding shares will decrease from approximately 47,996,572 to approximately 2,399,829 (subject to rounding).
- Trading Symbol: Remains "DRIO" on the Nasdaq Capital Market.
- CUSIP Number: Will change to 23725P 308.
- Fractional Shares: No fractional shares will be issued; holdings will be rounded up to the nearest whole share.
- Derivatives: All outstanding options, warrants, and convertible securities will be adjusted by dividing share counts by 20 and multiplying exercise/conversion prices by 20.
Guidance, Outlook, and Risks
The filing does not provide forward-looking guidance, management commentary on financial outlook, or specific risk factors beyond the standard mechanics of the reverse split. The Company notes that each shareholder's percentage ownership and proportional voting power will remain virtually unchanged, except for minor adjustments due to rounding.
Investor Verification Checklist
- Verify the new CUSIP number (23725P 308) for trading purposes starting August 28, 2025.
- Confirm the adjusted share count and exercise prices for any held options or warrants.
- Review the impact of rounding up fractional shares on total holdings.
- Monitor the stock price and trading volume on the effective date to assess market reaction to the split.